Minerva Surgical, Inc. (UTRS): Price and Financial Metrics

Minerva Surgical, Inc. (UTRS): $0.00

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add UTRS to Watchlist
Sign Up

Industry: Medical - Services

Industry

NR

Ranked

#32 of 85

in industry

UTRS Price/Volume Stats

Current price $0.00 52-week high $14.00
Prev. close $0.00 52-week low $0.00
Day low $0.00 Volume 26,100
Day high $0.00 Avg. volume 4,103
50-day MA $0.60 Dividend yield N/A
200-day MA $2.55 Market Cap 8.88K

UTRS Stock Price Chart Interactive Chart >


Minerva Surgical, Inc. (UTRS) Company Bio


Minerva Surgical Inc., a commercial-stage medical technology company, focuses on developing, manufacturing, and commercializing minimally invasive solutions to meet the uterine healthcare needs of women. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists across various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.


UTRS Latest News Stream


Event/Time News Detail
Loading, please wait...

UTRS Latest Social Stream


Loading social stream, please wait...

View Full UTRS Social Stream

Latest UTRS News From Around the Web

Below are the latest news stories about MINERVA SURGICAL INC that investors may wish to consider to help them evaluate UTRS as an investment opportunity.

ADBE Stock Alert: Adobe and Figma Terminate Merger Agreement

Adobe stock is up on Monday as investors in ADBE react to the company calling off its merger plans with Figma due to regulatory reasons.

William White on InvestorPlace | December 18, 2023

Goldman Sachs Is Souring on Nokia (NOK) Stock

Nokia stock is falling on Monday after shares of NOK were hit with a downgrade and lowered price target from Goldman Sachs.

William White on InvestorPlace | December 18, 2023

Why Is Minerva Surgical (UTRS) Stock Down 50% Today?

Minerva Surgical stock is falling hard on Monday after the women's healthcare company announced plans to delist UTRS shares.

William White on InvestorPlace | December 18, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

It's time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday morning!

William White on InvestorPlace | December 18, 2023

Minerva Surgical Reports Third Quarter 2023 Financial Results

SANTA CLARA, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women's health company focused on solutions to meet the distinct uterine healthcare needs of women, today reported third quarter financial results for the period ended September 30, 2023. Third Quarter Highlights: Reported revenue of $12.0 million in the third quarter of 2023, compared with revenue of $12.6 million in the third quarter of 2022Increased Symphion produc

Yahoo | November 13, 2023

Read More 'UTRS' Stories Here

UTRS Price Returns

1-mo N/A
3-mo 0.00%
6-mo 0.00%
1-year 0.00%
3-year N/A
5-year N/A
YTD 0.00%
2023 -73.81%
2022 -95.65%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!